RDEA806

RDEA806 · Ardea Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RDEA806, covering 2014-02-06 to 2014-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout [Phase 2]